Less Ads, More Data, More Tools Register for FREE

Media

Latest videos from London South East

08:13

RNS EXCLUSIVE: Cabot praise 3D seismic mapping after successful winter programme

Cabot Energy CEO Keith Bush announced the results of the winter work programme in Alberta today, describing them as 'better than expected'. He was keen to emphasise the successful use of 3D seismic t...

16:27

RNS EXCLUSIVE: HemoGenyx release successful CDX Antibody first data results

Dr Vladislav Sandler, Co-Founder and CEO of HemoGenyx Pharmaceuticals #LSE #HEMO discusses two major announcements with London South East. First data results show that CDX antibodies have b...

15:10

Angus Energy announces transformational joint venture with Cuadrilla & Lucas Energy

#ANGS is to form a joint venture with Cuadrilla Resources and Lucas Energy. Angus is to take a 25% stake in the Weald Balcombe licence for £4M and becomes the operating partner. This is funde...

10:34

TransGlobe Energy upps output and benefits from higher oil price

TransGlobe Energy announced a 27% increase in production last November, a nicely timed increase as the oil price rises. Randy Neely, TransGlobe’s President, fills us in on what else has been...

10:40

Frontera Resources starts Tiribani drilling campaign 'tonight'

Frontera Resources Chief Executive Zaza Mamulaishvili confirmed to London South East that a new drilling programme begins tonight on the Tiribani Field Block 12, in the south west of Georgia close to...

09:30

Colin Hutchinson, Ascent Resources CEO gives a strategy update

Ascent Resources CEO Colin Hutchinson sets out in detail his strategic approach for the next few years. He believes the Slovenian Environment Agency will grant a permit for a new processing plant to ...

14:43

Aim-listed Mongolian explorer Petro Matad to drill four wells in 2018

Mike Buck, new CEO of the only AIM-listed Mongolian oil explorer, Petro Matad, told London South East four wells are to be drilled in a 2018 work programme. In a bullish interview he explained tha...

14:29

Cabot Energy #CAB strikes a transformational deal in Canada with i-Pulse

Cabot Energy, listed on AIM as #CAB , have bought the remaining 25% of the oil-producing Canadian assets they operate in Alberta. In effect they become the operator of the field and all revenues ret...

14:35

Understanding 2018 markets with brokers London Stone Securities

Ranjeet Singh, Director at brokers London Stone Securities, and himself a long term investor, gives us his six monthly market update. Ranjeet discusses his investment trends for 2018 and tell us wher...

13:25

EXCLUSIVE: HemoGenyx are creating blood cancer treatments with US$9 billion market potential

#HEMO are a London-listed, US-based biotech company developing two revolutionary blood cancer treatments. CDX antibodies are intended to remove the need for chemo and radiation before a bone mar...

14:07

RNS VIDEO: Reabold Resources #RBD raise £6M and take stake in Danube Petroleum

Reabold Resources Co-Chief Executives Stephen Williams and Sachin Oza have just successfully raised 'approximately six million pounds' to invest in their innovative strategy. #RBD have also toda...

08:10

#PHARMA: Therapix Biosciences are developing 'medicinal cannabis' for Tourette's and sleep apnea

Josh Blacher, CFO at Therapix Biosciences, describes how his company are developing a therapeutic approach to obstructive sleep apnea, and in parallel are developing a synthetic cannabinoid-based tab...

06:26

#PHARMA: Quantum Genomics to launch new class of high blood pressure drug

Lionel Segard is Chairman & CEO of Quantum Genomics, a French biotech company launched 11 years ago. Quantam are developing 1st in class drugs to treat hypertension and chronic heart failure. ...

05:30

#PHARMA: Want to invest in PDL, the 'new Berkshire Hathaway' for Health Care?

Peter Garcia, the CFO at PDL BioPharma explains that in his view, PDL is 'unique'. Located in Lake Tahoe, Nevada, PDL is a publicly traded private equity group listed on Nasdaq: #PDLI . 'PDL allows ...

07:23

#PHARMA: NeuroVive are groundbreaking specialists in mitochondrial treatments

Erik Kinnman, CEO of Swedish biotech company NeuroVive Pharmaceutical, says that his company are at the forefront of research into mitochondrial medicine, which is the subject of growing interest. ...

04:53

#PHARMA: Volition expects to market 'revolutionary' colo-rectal cancer blood test Q3 2018

Cameron Reynolds, Volition CEO, told London South East he expects to hit significant clinical test milestones in 2018 and to get a CE Mark and to begin selling their colorectal cancer blood test in E...

06:21

#PHARMA: Race Oncology has a successful track record of profitably recycling old drugs

Peter Molloy, CEO at Race Oncology explains how his business speeds up taking drugs to market. Race look for old drug assets which have been developed and discarded by big pharma companies who chose ...

06:46

#PHARMA: Heat Biologics - a 'totally game-changing' lung cancer treatment, Phase II data Q3 2018

Heat Biologics is an immunotherapy cancer company based in North Carolina,and listed on Nasdaq: HTBX. Heat develop drugs for non small-cell lung cancer and are in Phase II development trials using a ...

03:57

#PHARMA: Neuvolution, a Swedish/Danish biotech, 'expect partnership agreements within 3/12 months'

Henrik Simonsen, CFO, Nuevolution explains that his biotech company is listed on the Nasdaq First North Premier Exchange, a Stockholm-based growth stock exchange. Neuvolution have unique tablet-ba...

13:53

EXCLUSIVE: President Energy, a profitable growth business, looks to double production by acquisition

PRESIDENT ENERGY: Peter Levine, CEO and Chairman, sums up President as 'a growth business on income, profitability and cash'. It is looking to double production from the current 2400 bopd organically...

09:55

ASCENT RESOURCES: Gas flows mean cash flows to develop up to 15 wells

ASCENT RESOURCES: Chief Executive Colin Hutchinson tells London South East that gas flowed from the Petisovci field in Slovenia to INA in Croatia last Thursday. They expect to be receiving around Eur...

11:55

CABOT ENERGY UPDATE: Latest 'better then expected' flow rates a boost for Canadian assets says CEO

Keith Bush, CEO at Cabot Energy explains why better than expected sidetrack well flow rates auger well for the future potential of their Alberta oil assets. 100 bpd of oil was expected, 680 bpd flowe...

15:27

EXCLUSIVE: Caspian Sunrise 'are looking at 10,000 barrels per day within months not years'

Caspian Sunrise Chairman Clive Carver gives us an in-depth update on exploration and strategy in Kazakhstan. A flow test is to start within days on the 3500 bpd A5 deep well, with Clive 'disappointed...

24:08

EXCLUSIVE: David Lenigas answers investor questions on Weald Basin, Cuba, medicinal cannabis

David Lenigas answers all your investor questions in a long and frank interview with London South East. ...